2018 Top 5 Checkpoint Inhibitors for Treating Cancer Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa

LP 2647884
125 Pages
July 2018
Pharmaceuticals

Download Sample Get Discount

Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.

Those four kinds of checkpoint inhibitors are mainly used to treat melanoma, bladder cancer and others. In 2015, melanoma treatment consumed checkpoint inhibitors took a share of 80.53%. In 2016, melanoma treatment consumed checkpoint inhibitors will be 68153g. Bladder cancer treatment consumed checkpoint inhibitors will be 1978g.

Although YERVOY® (ipilimumab), OPDIVO® (nivolumab), KEYTRUDA® (pembrolizumab) and Tecentriq® (atezolizumab) are four indispensable medicines for cancer treatment, they also has many shortages. Firstly, they all have side effect for patient. Secondly, price of checkpoint inhibitors for treating cancer is too expensive. CTLA-4 inhibitors price is about 118.2 USD/mg in 2016. PD-1 inhibitors price is about 28.6 USD/mg in 2016. PD-L1 inhibitors price is about 30.5 USD/mg in 2016. For most patients, the price is unbearable.

Over the next five years, LPI(LP Information) projects that Checkpoint Inhibitors for Treating Cancer will register a 28.0% CAGR in terms of revenue, reach US$ 20600 million by 2023, from US$ 4690 million in 2017.

This report studies the global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:

Bristol-Myers Squibb(BMS)

Merck

Roche

Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 (forecast), like

North America (United States, Canada and Mexico)

Asia-Pacific (China, Japan, Southeast Asia, India and Korea)

Europe (Germany, UK, France, Italy and Russia etc.)

South America (Brazil, Chile, Peru and Argentina)

Middle East and Africa (Egypt, South Africa, Saudi Arabia)

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into

PD-1 Inhibitors

PD-L1 Inhibitors

CTLA-4 Inhibitors

Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into

Melanoma Treatment

Bladder Cancer Treatment

Other

Table of Contents

2018 Top 5 Checkpoint Inhibitors for Treating Cancer Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa

1 Checkpoint Inhibitors for Treating Cancer Market Overview

1.1 Product Overview and Scope of Checkpoint Inhibitors for Treating Cancer

1.2 Checkpoint Inhibitors for Treating Cancer Segment by Types

1.2.1 Global Sales Market Share of Checkpoint Inhibitors for Treating Cancer by Types in 2017

1.2.2 PD-1 Inhibitors

1.2.2.1 Major Players of Type I

1.2.3 PD-L1 Inhibitors

1.2.3.1 Major Players of PD-L1 Inhibitors

1.2.4 CTLA-4 Inhibitors

1.2.4.1 Major Players of CTLA-4 Inhibitors

1.3 Checkpoint Inhibitors for Treating Cancer Segment by Applications

1.3.1 Checkpoint Inhibitors for Treating Cancer Sales Market Share by Applications in 2017

1.3.2 Melanoma Treatment

1.3.3 Bladder Cancer Treatment

1.3.4 Other

1.4 Checkpoint Inhibitors for Treating Cancer Market by Regions

1.4.1 North America Status and Prospect (2013-2023)

1.4.1.1 North America Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2023)

1.4.2 Asia-Pacific Status and Prospect (2013-2023)

1.4.2.1 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2023)

1.4.3 Europe Status and Prospect (2013-2023)

1.4.3.1 Europe Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2023)

1.4.4 South America Status and Prospect (2013-2023)

1.4.4.1 South America Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2023)

1.4.5 Middle East and Africa Status and Prospect (2013-2023)

1.4.5.1 Middle East and Africa Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2023)

1.5 Global Market Size (Value) of Checkpoint Inhibitors for Treating Cancer (2013-2023)

2 Global Checkpoint Inhibitors for Treating Cancer Sales, Revenue (Value) and Market Share by Players

2.1 Global Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Players in 2016 and 2017

2.1.1 Global Checkpoint Inhibitors for Treating Cancer Sales by Players in 2016 and 2017

2.1.2 Global Checkpoint Inhibitors for Treating Cancer Sales Market Share (%) by Players in 2016 and 2017

2.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Players in 2016 and 2017

2.2.1 Global Checkpoint Inhibitors for Treating Cancer Revenue by Players in 2016 and 2017

2.2.2 Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share (%) by Players in 2016 and 2017

2.3 Global Checkpoint Inhibitors for Treating Cancer Average Price by Players in 2016 and 2017

2.4 Global Checkpoint Inhibitors for Treating Cancer Manufacturing Base Distribution, Sales Area, Product Types by Players

2.4.1 Global Checkpoint Inhibitors for Treating Cancer Manufacturing Base Distribution and Sales Area by Players

2.4.2 Players Checkpoint Inhibitors for Treating Cancer Product Types

2.5 Checkpoint Inhibitors for Treating Cancer Market Competitive Situation and Trends

2.5.1 Checkpoint Inhibitors for Treating Cancer Market Concentration Rate

2.5.2 Checkpoint Inhibitors for Treating Cancer Market Share of Top 3 and Top 5 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Global Checkpoint Inhibitors for Treating Cancer Sales, Revenue (Value) by Regions, Type and Application (2013-2018)

3.1 Global Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Market Share by Regions (2013-2018)

3.1.1 Global Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Regions (2013-2018)

3.1.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Regions (2013-2018)

3.2 Global Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Market Share and Price by Type (2013-2018)

3.2.1 Global Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Type (2013-2018)

3.2.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Type (2013-2018)

3.2.3 Global Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)

3.3 Global Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Application (2013-2018)

3.3.1 Global Checkpoint Inhibitors for Treating Cancer Sales by Application (2013-2018)

3.3.2 Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

3.4 Global Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Price and Gross Margin (2013-2018)

4 North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Price

4.1 North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Market Share in 2016 and 2017

4.1.1 North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales and Market Share in 2016 and 2017

4.1.2 North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue and Market Share in 2016 and 2017

4.2 North America Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Market Share and Price by Type (2013-2018)

4.2.1 North America Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Type (2013-2018)

4.2.1.1 North America Checkpoint Inhibitors for Treating Cancer Sales by Type (2013-2018)

4.2.1.2 North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

4.2.2 North America Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Type (2013-2018)

4.2.2.1 North America Checkpoint Inhibitors for Treating Cancer Revenue by Type (2013-2018)

4.2.2.2 North America Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

4.2.3 North America Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)

4.3 North America Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Application (2013-2018)

4.3.1 North America Checkpoint Inhibitors for Treating Cancer Sales by Application (2013-2018)

4.3.2 North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

4.4 North America Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Country (US, Canada and Mexico) (2013-2018)

4.4.1 North America Checkpoint Inhibitors for Treating Cancer Sales by Country (2013-2018)

4.4.2 North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

4.5 North America Checkpoint Inhibitors for Treating Cancer Import & Export (2013-2018)

5 Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Price

5.1 Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Market Share in 2016 and 2017

5.1.1 Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales and Market Share in 2016 and 2017

5.1.2 Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue and Market Share in 2016 and 2017

5.2 Europe Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Market Share and Price by Type (2013-2018)

5.2.1 Europe Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Type (2013-2018)

5.2.1.1 Europe Checkpoint Inhibitors for Treating Cancer Sales by Type (2013-2018)

5.2.1.2 Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

5.2.2 Europe Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Type (2013-2018)

5.2.2.1 Europe Checkpoint Inhibitors for Treating Cancer Revenue by Type (2013-2018)

5.2.2.2 Europe Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

5.2.3 Europe Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)

5.3 Europe Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Application (2013-2018)

5.3.1 Europe Checkpoint Inhibitors for Treating Cancer Sales by Application (2013-2018)

5.3.2 Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

5.4 Europe Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Country (Germany, UK, France, Italy and Russia) (2013-2018)

5.4.1 Europe Checkpoint Inhibitors for Treating Cancer Sales by Country (2013-2018)

5.4.2 Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

5.5 Europe Checkpoint Inhibitors for Treating Cancer Import & Export (2013-2018)

6 Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Price

6.1 Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Market Share in 2016 and 2017

6.1.1 Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales and Market Share in 2016 and 2017

6.1.2 Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue and Market Share in 2016 and 2017

6.2 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Market Share and Price by Type (2013-2018)

6.2.1 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Type (2013-2018)

6.2.1.1 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales by Type (2013-2018)

6.2.1.2 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

6.2.2 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Type (2013-2018)

6.2.3 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)

6.3 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Application (2013-2018)

6.3.1 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales by Application (2013-2018)

6.3.2 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

6.4 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Country (China, Japan, Southeast Asia, India, Korea and Australia) (2013-2018)

6.4.1 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales by Country (2013-2018)

6.4.2 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

6.5 Asia-Pacific Checkpoint Inhibitors for Treating Cancer Import & Export (2013-2018)

7 South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Price

7.1 South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Market Share in 2016 and 2017

7.1.1 South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales and Market Share in 2016 and 2017

7.1.2 South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue and Market Share in 2016 and 2017

7.2 South America Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Market Share and Price by Type (2013-2018)

7.2.1 South America Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Type (2013-2018)

7.2.1.1 South America Checkpoint Inhibitors for Treating Cancer Sales by Type (2013-2018)

7.2.1.2 South America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

7.2.2 South America Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Type (2013-2018)

7.2.2.1 South America Checkpoint Inhibitors for Treating Cancer Revenue by Type (2013-2018)

7.2.2.2 South America Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Type (2013-2018)

7.2.3 South America Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)

7.3 South America Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Application (2013-2018)

7.3.1 South America Checkpoint Inhibitors for Treating Cancer Sales by Application (2013-2018)

7.3.2 South America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

7.4 South America Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Country (Brazil, Argentina, Chile and Peru) (2013-2018)

7.4.1 South America Checkpoint Inhibitors for Treating Cancer Sales by Country (2013-2018)

7.4.2 South America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

7.5 South America Checkpoint Inhibitors for Treating Cancer Import & Export (2013-2018)

8 Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Price

8.1 Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Market Share in 2016 and 2017

8.1.1 Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales and Market Share in 2016 and 2017

8.1.2 Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue and Market Share in 2016 and 2017

8.2 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Market Share and Price by Type (2013-2018)

8.2.1 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Type (2013-2018)

8.2.1.1 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales by Type (2013-2018)

8.2.1.2 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

8.2.2 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Type (2013-2018)

8.2.2.1 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Revenue by Type (2013-2018)

8.2.2.2 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

8.2.3 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)

8.3 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Application (2013-2018)

8.3.1 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales by Application (2013-2018)

8.3.2 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

8.4 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Country (Egypt, Saudi Arabia, South Africa and Iran) (2013-2018)

8.4.1 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales by Country (2013-2018)

8.4.2 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

8.5 Middle East & Africa Checkpoint Inhibitors for Treating Cancer Import & Export (2013-2018)

9 Global Checkpoint Inhibitors for Treating Cancer Players Profiles/Analysis

9.1 Bristol-Myers Squibb(BMS)

9.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

9.1.2 Checkpoint Inhibitors for Treating Cancer Product Types, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Price and Gross Margin (2013-2018)

9.1.4 Main Business/Business Overview

9.1.5 Bristol-Myers Squibb(BMS) News

9.2 Merck

9.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

9.2.2 Checkpoint Inhibitors for Treating Cancer Product Types, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 Merck Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Price and Gross Margin (2013-2018)

9.2.4 Main Business/Business Overview

9.2.5 Merck News

9.3 Roche

9.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

9.3.2 Checkpoint Inhibitors for Treating Cancer Product Types, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Roche Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Price and Gross Margin (2013-2018)

9.3.4 Main Business/Business Overview

9.3.5 Roche News

10 Global Checkpoint Inhibitors for Treating Cancer Market Forecast (2018-2023)

10.1 Global Checkpoint Inhibitors for Treating Cancer Sales, Revenue Forecast (2018-2023)

10.2 Global Checkpoint Inhibitors for Treating Cancer Sales, Consumption Forecast by Regions (2018-2023)

10.2.1 Global Checkpoint Inhibitors for Treating Cancer Sales Forecast by Regions (2018-2023)

10.2.2 Global Checkpoint Inhibitors for Treating Cancer Sales Market Share Forecast by Regions (2018-2023)

10.3 Global Checkpoint Inhibitors for Treating Cancer Sales and Market Share Forecast by Type (2018-2023)

10.3.1 Global Checkpoint Inhibitors for Treating Cancer Sales Forecast by Type (2018-2023)

10.3.2 Global Checkpoint Inhibitors for Treating Cancer Sales Market Share Forecast by Type (2018-2023)

10.4 Global Checkpoint Inhibitors for Treating Cancer Sales and Market Share Forecast by Application (2018-2023)

10.4.1 Global Checkpoint Inhibitors for Treating Cancer Sales Forecast by Application (2018-2023)

10.4.2 Global Checkpoint Inhibitors for Treating Cancer Sales Market Share Forecast by Application (2018-2023)

10.5 Checkpoint Inhibitors for Treating Cancer Price Forecast (2018-2023)

11 Checkpoint Inhibitors for Treating Cancer Manufacturing Cost Analysis

11.1 Checkpoint Inhibitors for Treating Cancer Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Checkpoint Inhibitors for Treating Cancer

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Checkpoint Inhibitors for Treating Cancer Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Checkpoint Inhibitors for Treating Cancer Major Players in 2017

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Market Effect Factors Analysis

14.1 Technology Progress/Risk

14.1.1 Substitutes Threat

14.1.2 Technology Progress in Related Industry

14.2 Consumer Needs/Customer Preference Change

14.3 Economic/Political Environmental Change

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology

16.2 Data Source

List of Tables and Figures

Figure Picture of Checkpoint Inhibitors for Treating Cancer

Table Product Specifications of Checkpoint Inhibitors for Treating Cancer

Figure Global Sales Market Share of Checkpoint Inhibitors for Treating Cancer by Types in 2017

Figure Product Picture of PD-1 Inhibitors

Table Major Players of PD-1 Inhibitors

Figure Product Picture of PD-L1 Inhibitors

Table Major Players of PD-L1 Inhibitors

Figure Product Picture of CTLA-4 Inhibitors

Table Major Players of CTLA-4 Inhibitors

Figure Checkpoint Inhibitors for Treating Cancer Sales Market Share by Applications in 2017

Table Applications of Checkpoint Inhibitors for Treating Cancer

Figure Bladder Cancer Treatment Examples

Figure Other Examples

Figure North America Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Table Global Checkpoint Inhibitors for Treating Cancer Sales by Players in 2016 and 2017

Table Global Checkpoint Inhibitors for Treating Cancer Sales Market Share (%) by Players in 2016 and 2017

Figure Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Players in 2016

Figure Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Players in 2017

Table Global Checkpoint Inhibitors for Treating Cancer Revenue by Players in 2016 and 2017

Table Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share (%) by Players in 2016 and 2017

Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Players in 2016

Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Players in 2017

Table Global Checkpoint Inhibitors for Treating Cancer Average Price by Players in 2016 and 2017

Figure Global Checkpoint Inhibitors for Treating Cancer Average Price by Players in 2017

Table Global Checkpoint Inhibitors for Treating Cancer Manufacturing Base Distribution and Sales Area by Players

Table Players Checkpoint Inhibitors for Treating Cancer Product Types

Figure Checkpoint Inhibitors for Treating Cancer Market Share of Top 3 Players

Figure Checkpoint Inhibitors for Treating Cancer Market Share of Top 5 Players

Table Global Checkpoint Inhibitors for Treating Cancer Sales by Regions (2013-2018)

Table Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Regions (2013-2018)

Figure Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Regions (2013-2018)

Figure Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Regions in 2017

Table Global Checkpoint Inhibitors for Treating Cancer Revenue by Regions (2013-2018)

Table Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Regions (2013-2018)

Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Regions (2013-2018)

Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Regions in 2017

Table Global Checkpoint Inhibitors for Treating Cancer Sales by Type (2013-2018)

Table Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

Figure Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

Figure Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type in 2017

Table Global Checkpoint Inhibitors for Treating Cancer Revenue by Type (2013-2018)

Table Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type in 2017

Table Global Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)

Table Global Checkpoint Inhibitors for Treating Cancer Sales by Application (2013-2018)

Figure Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application in 2017

Table Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

Figure Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

Table Global Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Price and Gross Margin (2013-2018)

Table North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales in 2016 and 2017

Table North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Market Share (%) in 2016 and 2017

Figure North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Share in 2016

Figure North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Share in 2017

Table North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue in 2016 and 2017

Table North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Market Share (%) in 2016 and 2017

Figure North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Share in 2016

Figure North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Share in 2017

Table North America Checkpoint Inhibitors for Treating Cancer Sales by Type (2013-2018)

Figure 2017 North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type

Table North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

Figure North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

Table North America Checkpoint Inhibitors for Treating Cancer Revenue by Type (2013-2018)

Figure North America Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type in 2017

Table North America Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

Figure North America Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

Table North America Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)

Table North America Checkpoint Inhibitors for Treating Cancer Sales by Application (2013-2018)

Figure North America Checkpoint Inhibitors for Treating Cancer Sales by Application in 2017

Table North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

Figure North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

Table North America Checkpoint Inhibitors for Treating Cancer Sales by Country (2013-2018)

Figure 2017 North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country

Table North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

Figure North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

Table North America Checkpoint Inhibitors for Treating Cancer Import & Export (2013-2018)

Table Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales in 2016 and 2017

Table Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Market Share (%) in 2016 and 2017

Figure Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Share in 2016

Figure Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Share in 2017

Table Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue in 2016 and 2017

Table Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Market Share (%) in 2016 and 2017

Figure Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Share in 2016

Figure Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Share in 2017

Table Europe Checkpoint Inhibitors for Treating Cancer Sales by Type (2013-2018)

Figure 2017 Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type

Table Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

Figure Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

Table Europe Checkpoint Inhibitors for Treating Cancer Revenue by Type (2013-2018)

Figure Europe Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type in 2017

Table Europe Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

Figure Europe Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

Table Europe Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)

Table Europe Checkpoint Inhibitors for Treating Cancer Sales by Application (2013-2018)

Figure Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application in 2017

Table Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

Figure Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

Table Europe Checkpoint Inhibitors for Treating Cancer Sales by Country (2013-2018)

Figure Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country in 2017

Table Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

Figure Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

Table Europe Checkpoint Inhibitors for Treating Cancer Import & Export (2013-2018)

Table Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales in 2016 and 2017

Table Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Market Share (%) in 2016 and 2017

Figure Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Share in 2016

Figure Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Share in 2017

Table Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue in 2016 and 2017

Table Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Market Share (%) in 2016 and 2017

Figure Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Share in 2016

Figure Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Share in 2017

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales by Type (2013-2018)

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type in 2017

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Revenue by Type (2013-2018)

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type in 2017

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales by Application (2013-2018)

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales by Application in 2017

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales by Country (2013-2018)

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country in 2017

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Import & Export (2013-2018)

Table South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales in 2016 and 2017

Table South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Market Share (%) in 2016 and 2017

Figure South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Share in 2016

Figure South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Share in 2017

Table South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue in 2016 and 2017

Table South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Market Share (%) in 2016 and 2017

Figure South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Share in 2016

Figure South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Share in 2017

Table South America Checkpoint Inhibitors for Treating Cancer Sales by Type (2013-2018)

Figure South America Checkpoint Inhibitors for Treating Cancer Sales by Type in 2017

Table South America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

Figure South America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

Table South America Checkpoint Inhibitors for Treating Cancer Revenue by Type (2013-2018)

Figure South America Checkpoint Inhibitors for Treating Cancer Revenue by Type in 2017

Table South America Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

Figure South America Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

Table South America Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)

Table South America Checkpoint Inhibitors for Treating Cancer Sales by Application (2013-2018)

Figure South America Checkpoint Inhibitors for Treating Cancer Sales by Application in 2017

Table South America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

Figure South America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

Table South America Checkpoint Inhibitors for Treating Cancer Sales by Country (2013-2018)

Figure South America Checkpoint Inhibitors for Treating Cancer Sales by Country in 2017

Table South America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

Figure South America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

Table South America Checkpoint Inhibitors for Treating Cancer Import & Export (2013-2018)

Table Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales in 2016 and 2017

Table Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Market Share (%) in 2016 and 2017

Figure Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Share in 2016

Figure Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales Share in 2017

Table Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue in 2016 and 2017

Table Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Market Share (%) in 2016 and 2017

Figure Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Share in 2016

Figure Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Revenue Share in 2017

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales by Type (2013-2018)

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales by Type in 2017

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2013-2018)

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Revenue by Type (2013-2018)

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Revenue by Type in 2017

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2013-2018)

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales by Application (2013-2018)

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales by Application in 2017

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales by Country (2013-2018)

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales by Country in 2017

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2013-2018)

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Import & Export (2013-2018)

Table Bristol-Myers Squibb(BMS) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Price and Gross Margin (2013-2018)

Figure Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Market Share (2013-2018)

Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Price and Gross Margin (2013-2018)

Figure Merck Checkpoint Inhibitors for Treating Cancer Market Share (2013-2018)

Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Roche Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Price and Gross Margin (2013-2018)

Figure Roche Checkpoint Inhibitors for Treating Cancer Market Share (2013-2018)

Figure Global Checkpoint Inhibitors for Treating Cancer Sales and Growth Rate Forecast (2018-2023)

Figure Global Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate Forecast (2018-2023)

Table Global Checkpoint Inhibitors for Treating Cancer Sales Forecast by Regions (2018-2023)

Table Global Checkpoint Inhibitors for Treating Cancer Sales Market Share Forecast by Regions (2018-2023)

Table Global Checkpoint Inhibitors for Treating Cancer Sales Forecast by Type (2018-2023)

Table Global Checkpoint Inhibitors for Treating Cancer Sales Market Share Forecast by Type (2018-2023)

Table Global Checkpoint Inhibitors for Treating Cancer Sales Forecast by Application (2018-2023)

Table Global Checkpoint Inhibitors for Treating Cancer Sales Market Share Forecast by Application (2018-2023)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Checkpoint Inhibitors for Treating Cancer

Figure Manufacturing Process Analysis of Checkpoint Inhibitors for Treating Cancer

Figure Checkpoint Inhibitors for Treating Cancer Industrial Chain Analysis

Table Raw Materials Sources of Checkpoint Inhibitors for Treating Cancer Major Players in 2017

Table Major Buyers of Checkpoint Inhibitors for Treating Cancer

Table Distributors/Traders List

Purchase Options

Single User License $4960 Multiple $7440 Corporate $9920

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

Publish Date: November 14, 2017
$5370

View Details

Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

Publish Date: July 20, 2017
$5370

View Details

Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

Publish Date: April 24, 2017
$5370

View Details

Client Testimonials

Your team has worked hard to help and to provide our research needs to fulfill our significant initiatives...

Maria

-Researcher

The report on EAA resins was detailed and informative. However, we were hopeful to discover a Chinese producer ...

David

-President Protech Oxyplast Group

Thanks the attached report is perfect and accurate, but I was wondering if you can show the price trend in one year...

2018 Top 5 Checkpoint Inhibitors for Treating Cancer Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara